These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36335479)

  • 21. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
    Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B; Drazner MH; Fong MW; Givertz MM; Gordon RA; Jermyn R; Katz SD; Lamba S; Lanfear DE; LaRue SJ; Lindenfeld J; Malone M; Margulies K; Mentz RJ; Mutharasan RK; Pursley M; Umpierrez G; Kosiborod M
    Circulation; 2019 Oct; 140(18):1463-1476. PubMed ID: 31524498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
    Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
    Siddiqi AK; Maniya MT; Alam MT; Ambrosy AP; Fudim M; Greene SJ; Khan MS
    Am J Cardiovasc Drugs; 2024 Mar; 24(2):273-284. PubMed ID: 38416359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
    Imiela T; Budaj A
    Clin Drug Investig; 2017 Dec; 37(12):1175-1181. PubMed ID: 28965280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
    Dauw J; Lelonek M; Zegri-Reiriz I; Paredes-Paucar CP; Zara C; George V; Cobo-Marcos M; Knappe D; Shchekochikhin D; Lekhakul A; Klincheva M; Frea S; Miró Ò; Barker D; Borbély A; Nasr S; Doghmi N; de la Espriella R; Singh JS; Bovolo V; Fialho I; Ross NT; van den Heuvel M; Benkouar R; Findeisen H; Alhaddad IA; Al Balbissi K; Barge-Caballero G; Ghazi AM; Bruckers L; Martens P; Mullens W
    ESC Heart Fail; 2021 Dec; 8(6):4685-4692. PubMed ID: 34708555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
    Solomon SD; Ostrominski JW; Vaduganathan M; Claggett B; Jhund PS; Desai AS; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Abidin IZ; Alcocer-Gamba MA; Atherton JJ; Bauersachs J; Ma CS; Chiang CE; Chioncel O; Chopra V; Comin-Colet J; Filippatos G; Fonseca C; Gajos G; Goland S; Goncalvesová E; Kang SM; Katova T; Kosiborod MN; Latkovskis G; Lee AP; Linssen GCM; Llamas-Esperón G; Mareev V; Martinez FA; Melenovský V; Merkely B; Nodari S; Petrie MC; Saldarriaga CI; Saraiva JFK; Sato N; Schou M; Sharma K; Troughton R; Udell JA; Ukkonen H; Vardeny O; Verma S; von Lewinski D; Voronkov LG; Yilmaz MB; Zieroth S; Lay-Flurrie J; van Gameren I; Amarante F; Viswanathan P; McMurray JJV
    Eur J Heart Fail; 2024 Jun; 26(6):1334-1346. PubMed ID: 38733212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Kapelios CJ; Greene SJ; Mentz RJ; Ikeaba U; Wojdyla D; Anstrom KJ; Eisenstein EL; Pitt B; Velazquez EJ; Fang JC;
    Circ Heart Fail; 2024 Mar; 17(3):e011246. PubMed ID: 38436075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
    Chatur S; Vaduganathan M; Claggett BL; Cunningham JW; Docherty KF; Desai AS; Jhund PS; de Boer RA; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez FA; Shah SJ; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
    Circulation; 2023 Nov; 148(22):1735-1745. PubMed ID: 37632455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial.
    Solomon SD; Vaduganathan M; Claggett BL; de Boer RA; DeMets D; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Belohlavek J; Chiang CE; Willem Borleffs CJ; Comin-Colet J; Dobreanu D; Drozdz J; Fang JC; Alcocer Gamba MA; Al Habeeb W; Han Y; Cabrera Honorio JW; Janssens SP; Katova T; Kitakaze M; Merkely B; O'Meara E; Kerr Saraiva JF; Tereschenko SN; Thierer J; Vardeny O; Verma S; Vinh PN; Wilderäng U; Zaozerska N; Lindholm D; Petersson M; McMurray JJV
    JACC Heart Fail; 2022 Mar; 10(3):184-197. PubMed ID: 35241246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination diuretic therapy in heart failure].
    Massop K; Kramers CK
    Ned Tijdschr Geneeskd; 2023 May; 167():. PubMed ID: 37257097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
    Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV
    Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial.
    Vaduganathan M; Claggett BL; Jhund P; de Boer RA; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Desai AS; Hegde SM; Lindholm D; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
    JAMA Cardiol; 2022 Dec; 7(12):1259-1263. PubMed ID: 36190011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
    Shah SJ; Sharma K; Borlaug BA; Butler J; Davies M; Kitzman DW; Petrie MC; Verma S; Patel S; Chinnakondepalli KM; Einfeldt MN; Jensen TJ; Rasmussen S; Asleh R; Ben-Gal T; Kosiborod MN
    Eur Heart J; 2024 Sep; 45(35):3254-3269. PubMed ID: 38739118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial.
    Lund LH; Savarese G; Venkateshvaran A; Benson L; Lundberg A; Donal E; Daubert JC; Oger E; Linde C; Hage C
    ESC Heart Fail; 2022 Feb; 9(1):164-177. PubMed ID: 34811954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study.
    Dauw J; Charaya K; Lelonek M; Zegri-Reiriz I; Nasr S; Paredes-Paucar CP; Borbély A; Erdal F; Benkouar R; Cobo-Marcos M; Barge-Caballero G; George V; Zara C; Ross NT; Barker D; Lekhakul A; Frea S; Ghazi AM; Knappe D; Doghmi N; Klincheva M; Fialho I; Bovolo V; Findeisen H; Alhaddad IA; Galluzzo A; de la Espriella R; Tabbalat R; Miró Ò; Singh JS; Nijst P; Dupont M; Martens P; Mullens W
    Circ Heart Fail; 2024 Jan; 17(1):e011105. PubMed ID: 38179728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
    Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Fujikawa K; Hata M; Fujita Y; Umayahara Y; Taniuchi S; Sanada S; Shintani A; Fukunami M
    Circ Heart Fail; 2021 Mar; 14(3):e007048. PubMed ID: 33663235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
    Martens P; Chen HH; Verbrugge FH; Testani JT; Mullens W; Tang WHW
    Eur J Heart Fail; 2022 Oct; 24(10):1978-1987. PubMed ID: 36054180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.